STOCK TITAN

Executive sells under 10b5-1 plan — RELY (NASDAQ: RELY) reports trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Company: RELY — Form 144 reporting proposed sales by an executive under pre-arranged plans.

The filing lists 16,800 shares as securities to be sold, identified as Previously Exercised Stock Options (10/07/2018). The filing shows multiple 10b5-1 plan sales executed in April–June 2026, with examples including 6,500 shares for $134,919.20 on 06/17/2026 and 33,600 shares for $706,608.00 on 06/01/2026. It also states total shares outstanding of 210,561,079 as of 06/29/2026.

Positive

  • None.

Negative

  • None.
Securities to be sold 16,800 shares Previously Exercised Stock Options dated 10/07/2018
Shares outstanding 210,561,079 shares as of 06/29/2026
Example trade (06/17/2026) 6,500 shares for $134,919.20 10b5-1 Sales Plan execution
Example trade (06/01/2026) 33,600 shares for $706,608.00 10b5-1 Sales Plan execution
Example trade (06/17/2026) 9,533 shares for $197,898.41 10b5-1 Sales Plan execution
10b5-1 Sales Plan regulatory
"10b5-1 Sales Plan for JOSHUA D. HUG 401 Union Street..."
A 10b5-1 sales plan is a written, prearranged schedule that company insiders use to buy or sell their employer’s stock under a U.S. securities rule, so trades occur automatically at set times or prices regardless of later private information. It matters to investors because it reduces the risk of insider-trading accusations and signals that certain insider trades were planned ahead—like putting transactions on autopilot—while still affecting share supply and market confidence.
Previously Exercised Stock Options financial
"Previously Exercised Stock Options | Issuer | 10/07/2018"
Cash financial
"Previously Exercised Stock Options ... | Cash"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does RELY's Form 144 disclose about planned sales?

The filing discloses proposed sales of 16,800 shares tied to previously exercised options. It lists these as stemming from options dated 10/07/2018 and shows multiple executed 10b5-1 plan sales in April–June 2026 as examples.

Who is the reported seller in the RELY Form 144 and how were sales implemented?

The sales are reported under a 10b5-1 Sales Plan for Joshua D. Hug. The entries show executed plan transactions (brokered cash sales) with dates and per‑trade proceeds in April–June 2026.

How many RELY shares were outstanding according to this filing?

The filing lists 210,561,079 shares outstanding as of 06/29/2026. That figure appears on the form's securities/issuer information lines and provides a baseline for scale comparisons.

What trade examples and proceeds are shown on RELY's Form 144?

Examples include 6,500 shares for $134,919.20 on 06/17/2026 and 33,600 shares for $706,608.00 on 06/01/2026. Multiple executed 10b5-1 plan sales with dates and gross proceeds are listed.

Are the shares being sold by RELY or by a selling holder?

The form indicates the sales are by the reporting holder (selling under a 10b5-1 plan) from previously exercised options. The entry labels the securities as "Issuer" origin and the method as cash sales.